Canada Life’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $88K | Sell |
16,127
-4,458
| -22% | -$25K | ﹤0.01% | 1702 |
|
|
2025
Q4 | $144K | Sell |
20,585
-39,646
| -66% | -$310K | ﹤0.01% | 1671 |
|
|
2025
Q3 | $494K | Buy |
60,231
+4,458
| +8% | +$34.8K | ﹤0.01% | 1600 |
|
|
2025
Q2 | $486K | Hold |
55,773
| – | – | ﹤0.01% | 1610 |
|
|
2025
Q1 | $444K | Hold |
55,773
| – | – | ﹤0.01% | 1634 |
|
|
2024
Q4 | $507K | Hold |
55,773
| – | – | ﹤0.01% | 1638 |
|
|
2024
Q3 | $513K | Sell |
55,773
-24,176
| -30% | -$200K | ﹤0.01% | 1668 |
|
|
2024
Q2 | $783K | Buy |
79,949
+7,111
| +10% | +$86.7K | ﹤0.01% | 1565 |
|
|
2024
Q1 | $1.1M | Sell |
72,838
-100,385
| -58% | -$1.82M | ﹤0.01% | 1482 |
|
|
2023
Q4 | $3.71M | Buy |
173,223
+16,064
| +10% | +$296K | 0.01% | 927 |
|
|
2023
Q3 | $2.92M | Buy |
157,159
+28,436
| +22% | +$664K | 0.01% | 999 |
|
|
2023
Q2 | $3.28M | Buy |
128,723
+98,974
| +333% | +$2.49M | 0.01% | 927 |
|
|
2023
Q1 | $772K | Buy |
29,749
+21,272
| +251% | +$569K | ﹤0.01% | 1572 |
|
|
2022
Q4 | $202K | Sell |
8,477
-88,402
| -91% | -$2.38M | ﹤0.01% | 1885 |
|
|
2022
Q3 | $2.46M | Buy |
96,879
+177
| +0.2% | +$6.21K | 0.01% | 1062 |
|
|
2022
Q2 | $3.21M | Sell |
96,702
-11,206
| -10% | -$476K | 0.01% | 893 |
|
|
2022
Q1 | $8.24M | Buy |
107,908
+10,559
| +11% | +$761K | 0.02% | 636 |
|
|
2021
Q4 | $8.91M | Buy |
97,349
+14,120
| +17% | +$1.69M | 0.02% | 622 |
|
|
2021
Q3 | $10.6M | Buy |
83,229
+24,820
| +42% | +$3.61M | 0.02% | 564 |
|
|
2021
Q2 | $9.71M | Buy |
58,409
+6,841
| +13% | +$1.11M | 0.02% | 610 |
|
|
2021
Q1 | $9.31M | Buy |
51,568
+3,511
| +7% | +$814K | 0.02% | 621 |
|
|
2020
Q4 | $9.59M | Buy |
48,057
+13,606
| +39% | +$2.77M | 0.02% | 630 |
|
|
2020
Q3 | $7.55M | Buy |
34,451
+13,289
| +63% | +$2.81M | 0.02% | 611 |
|
|
2020
Q2 | $4.02M | Buy |
21,162
+16,441
| +348% | +$2.88M | 0.01% | 757 |
|
|
2020
Q1 | $738K | Hold |
4,721
| – | – | ﹤0.01% | 1443 |
|
|
2019
Q4 | $392K | Hold |
4,721
| – | – | ﹤0.01% | 1775 |
|
|
2019
Q3 | $320K | Sell |
4,721
-3,147
| -40% | -$207K | ﹤0.01% | 959 |
|
|
2019
Q2 | $521K | Sell |
7,868
-351
| -4% | -$20.5K | ﹤0.01% | 1759 |
|
|
2019
Q1 | $456K | Buy |
8,219
+1,066
| +15% | +$65.1K | ﹤0.01% | 1660 |
|
|
2018
Q4 | $342K | Sell |
7,153
-28,200
| -80% | -$1.73M | ﹤0.01% | 1795 |
|
|
2018
Q3 | $3.06M | Buy |
35,353
+217
| +0.6% | +$15.5K | 0.01% | 901 |
|
|
2018
Q2 | $2.04M | Buy |
35,136
+3,236
| +10% | +$158K | ﹤0.01% | 1164 |
|
|
2018
Q1 | $1.28M | Sell |
31,900
-24,890
| -44% | -$940K | ﹤0.01% | 1399 |
|
|
2017
Q4 | $1.98M | Sell |
56,790
-390
| -0.7% | -$13K | ﹤0.01% | 1187 |
|
|
2017
Q3 | $1.89M | Buy |
57,180
+28,000
| +96% | +$918K | ﹤0.01% | 1198 |
|
|
2017
Q2 | $1.01M | Buy |
29,180
+24,980
| +595% | +$728K | ﹤0.01% | 1514 |
|
|
2017
Q1 | $105K | Buy |
+4,200
| New | +$87.4K | ﹤0.01% | 2102 |
|
|
2016
Q4 | – | Sell |
-5,094
| Closed | -$93K | – | 2541 |
|
|
2016
Q3 | $93K | Buy |
+5,094
| New | +$89.3K | ﹤0.01% | 2160 |
|
Other funds holding TDOC
VPM
VCM
VC
Canada Life's TDOC Position: Q1 2026 in Review
Canada Life reduced its Teladoc Health (TDOC) stake by 22% in Q1 2026, selling an estimated $25K and leaving 16,127 shares worth $88K. The position accounts for ﹤0.01% of the portfolio, ranked #1702.
Canada Life first reported a position in TDOC in Q3 2016 and has held it in 38 quarters since. The position peaked at $10.6M in Q3 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- Canada Life held 16,127 shares of Teladoc Health worth $88K as of Q1 2026.
- Canada Life sold 4,458 Teladoc Health shares in Q1 2026, an estimated $25K.
- Teladoc Health made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1702 holding.
- Canada Life first reported a position in Teladoc Health in Q3 2016 and has held it in 38 quarters since.
- Canada Life's Teladoc Health position peaked at $10.6M in Q3 2021.
- 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.